Follow the CSL share price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on the AU market, under the supervision of ASX. The latest transaction was reported on 27 August 2026 (Mixed). Among the most active insiders: Ms Alison Watkins AM. All data is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
0@ A$219.8749100.0% of flowShareASXASX:2924-03127583-3A700132
7 of 7 declarations
About CSL
CSL is an Australian biopharmaceutical company focused on developing treatments for serious diseases. It is listed on the Australian Securities Exchange under the ticker CSL.